COVID-19 NMA Summary Report

Overview

Since the early months of the COVID-19 pandemic (March 2020), the COVID-NMA initiative, an international initiative working in conjunction with the World Health Organization (WHO), and led by a team of researchers from Cochrane and other institutions, has been producing relevant, accessible, up-to-date, and trustworthy synthesis of high-quality evidence about the efficacy and safety of interventions for the prevention or treatment of COVID-19, as well as mapping the trial evidence.

 

WHO Team
R&D Blue Print (RDB)